JANX R&D to Revenue
Janux Therapeutics Inc · R&D to Revenue
JANX R&D to Revenue
Latest reported1258.96%period ending
JANX FY R&D/Revenue (0.00% → 1258.96%)
Latest values, visible window
High-resolution chart · PNG
JANX r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 1,258.96% | |
| 645.901% | |
| 679.4754% | |
| 620.5411% | |
| 721.3913% | |
| 0% | |
| 0% |